Caladrius Biosciences, Inc.
(NASDAQ : CLBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Wholesale Distributors
symbolcompany%chnglast%shortavg$volume
GWWW.W. Grainger, Inc.
8.50%197.8611.5%$162.71m
FASTFastenal Company
1.36%47.907.0%$134.90m
GPCGenuine Parts Company
0.91%96.881.8%$89.30m
HDSHD Supply Holdings, Inc.
1.04%35.851.7%$85.69m
BECNBeacon Roofing Supply, Inc.
1.89%53.732.5%$55.15m
MSMMSC Industrial Direct Co., Inc. Class A
3.68%78.354.0%$37.24m
POOLPool Corporation
-0.99%111.822.1%$27.27m
UNVRUnivar, Inc.
-1.39%29.741.4%$21.01m
WCCWESCO International, Inc.
2.52%60.952.9%$19.33m
DNOWNOW Inc
1.61%13.276.1%$18.65m
INTWorld Fuel Services Corporation
0.28%35.363.6%$15.04m
MRCMRC Global Inc.
0.33%18.315.0%$11.71m
AITApplied Industrial Technologies, Inc.
0.59%64.271.2%$11.59m
SUNSunoco LP
-1.11%31.253.5%$7.37m
APUAmeriGas Partners, L.P.
0.26%44.872.3%$6.47m

Company Profile

Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.